Plasticity of CD4+ FoxP3+ T cells

Current Opinion in Immunology

Volumn 21, Issue 3, 2009, Pages 281-285

  Zhou, Xuyu ^a   Bailey Bucktrout, Samantha ^a   Jeker, Lukas T ^a   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANTIGEN RECOGNITION; AUTOIMMUNITY; BINDING AFFINITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL LINEAGE; CYTOKINE PRODUCTION; CYTOLOGY; DOWN REGULATION; EFFECTOR CELL; IMMUNOLOGICAL TOLERANCE; INFECTION; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MEMORY T LYMPHOCYTE; NONHUMAN; PLASTICITY; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-17;

EID: 67049168780     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.05.007     Document Type: Review

References (38)

1. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
2. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., and Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
3. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
4. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
5. Khattri R., Cox T., Yasayko S., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4 (2003) 337-342
6. Tang Q., and Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9 (2008) 239-244
7. Pennington D.J., Silva-Santos B., Silberzahn T., Escórcio-Correia M., Woodward M.J., Roberts S.J., Smith A.L., Dyson P.J., and Hayday A.C. Early events in the thymus affect the balance of effector and regulatory T cells. Nature 444 (2006) 1073-1077
8. Lio C.J., and Hsieh C. A two-step process for thymic regulatory T cell development. Immunity 28 (2008) 100-111
9. Hsieh C., Liang Y., Tyznik A.J., Self S.G., Liggitt D., and Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21 (2004) 267-277
10. Pacholczyk R., Kern J., Singh N., Iwashima M., Kraj P., and Ignatowicz L. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity 27 (2007) 493-504
11. van Santen H., Benoist C., and Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med 200 (2004) 1221-1230
12. Burchill M.A., Yang J., Vang K.B., Moon J.J., Chu H.H., Lio C.J., Vegoe A.L., Hsieh C., Jenkins M.K., and Farrar M.A. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28 (2008) 112-121
13. Tang Q., Henriksen K.J., Boden E.K., Tooley A.J., Ye J., Subudhi S.K., Zheng X.X., Strom T.B., and Bluestone J.A. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 171 (2003) 3348-3352
14. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
15. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., Schlawe K., Chang H., Bopp T., Schmitt E., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5 (2007) e38. In this study, the authors identified a new conserved CpG region implicated in FoxP3 stability.
16. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., and Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775. The study demonstrated a critical role of Foxp3 in the maintenance of the Treg lineage.
17. Komatsu N., Mariotti-Ferrandiz M.E., Wang Y., Malissen B., Waldmann H., and Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 106 (2009) 1903-1908. This study shows that a large percentage of Treg lose Foxp3 expression after been transferred into a lymphopenic host, and the cells losing Foxp3 produced IL-17 and IFNγ.
18. Zhou X., Jeker L.T., Fife B.T., Zhu S., Anderson M.S., and McManus M.T. Bluestone JA: Selective miRNA disruption in Treg cells leads to uncontrolled autoimmunity. J Exp Med 205 (2008) 1983-1991. By using genetic fate mapping, the study demonstrated the critical role of miRNAs in maintaining Treg identity.
19. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., Piccirillo C.A., Salomon B.L., and Bluestone J.A. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28 (2008) 687-697. This study showed the intraislet Treg cell dysfunction correlated type I diabetes progression, and Treg cell dysfunction was largely because of an IL-2 deficiency.
20. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Bäckström B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13 (2007) 423-431
21. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770. This study demonstrated decreased Foxp3 expression in intraislet Treg from the NOD strain and that high levels of Foxp3 expression are critical in preventing autoimmune disease.
22. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
23. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., Shah B., Chang S.H., Schluns K.S., Watowich S.S., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29 (2008) 44-56. In this study, the authors demonstrated that the Treg lineage can be unstable under inflammatory conditions. IL-6 and TCR signal together induced FoxP3 downregulation and led to the development Th17 cells.
24. Lal G., Zhang N., van der Touw W., Ding Y., Ju W., Bottinger E.P., Reid S.P., Levy D.E., and Bromberg J.S. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 182 (2009) 259-273. In this study, conserved CpG-rich regions located in the upstream of FoxP3 promoter were identified, which might play an important role in maintaining Foxp3 stability.
25. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., and Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81 (2005) 45-52
26. Williams L.M., and Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8 (2007) 277-284
27. Egawa T., Tillman R.E., Naoe Y., Taniuchi I., and Littman D.R. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J Exp Med 204 (2007) 1945-1957
28. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., Knight Z.A., Cobb B.S., Cantrell D., O'Connor E., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105 (2008) 7797-7802
29. Haxhinasto S., Mathis D., and Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 205 (2008) 565-574
30. Mantel P., Kuipers H., Boyman O., Rhyner C., Ouaked N., Rückert B., Karagiannidis C., Lambrecht B.N., Hendriks R.W., Crameri R., et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 5 (2007) e329
31. Takaki H., Ichiyama K., Koga K., Chinen T., Takaesu G., Sugiyama Y., Kato S., Yoshimura A., and Kobayashi T. STAT6 inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J Biol Chem 283 (2008) 14955-14962
32. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R.A., Mitsdoerffer M., Strom T.B., Elyaman W., Ho I., et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9 (2008) 1347-1355
33. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., Smale S.T., Sakaguchi S., Livesey F.J., Fisher A.G., et al. A role for Dicer in immune regulation. J Exp Med 203 (2006) 2519-2527
34. Liston A., Lu L., O'Carroll D., Tarakhovsky A., and Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205 (2008) 1993-2004
35. Chong M.M.W., Rasmussen J.P., Rudensky A.Y., Rudensky A.Y., and Littman D.R. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205 (2008) 2005-2017
36. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T., Corcoran L., Treuting P., Klein U., and Rudensky A.Y. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458 (2009) 351-356
37. Lund J.M., Hsing L., Pham T.T., and Rudensky A.Y. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320 (2008) 1220-1224. This study reported an unexpected benefit of Treg in fighting virus infection using FoxP3 DTR knockin mice.
38. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., and Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol. 10 (2009) 595-602